Stuart Munro, MD

Articles by Stuart Munro, MD

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

ByTara L. Purvis, PharmD, BCPP,Leigh Anne Nelson, PharmD, BCPP,Ellie S. R. Elliott, PharmD, BCPP,Robin N. Hieber, PharmD, BCPP,Yifei Liu, BS Pharm, PhD,Richard H. Pham, PharmD,Stuart Munro, MD,an

October 5th 2011

Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.

Latest Updated Articles

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital
October 5th 2011

Stuart Munro, MD

Articles by Stuart Munro, MD

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

Latest Updated Articles

Trending on Pharmacy Times

FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief

Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know

FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening

“Can I Take This With My Other Medicine?”: Understanding Drug Interactions

Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds